Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sandostatin LAR for Chemoradiation-Induced Diarrhea in Anal or Rectal Cancer
NCT00075868Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Dec 2003
- Primary completion
- Aug 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of octreotide in diarrhea, sponsored by NRG Oncology. Started Dec 2003; status: completed.
02
Drugs
octreotide
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT00075868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075868.